SHE Center at Dana-Farber and Silverberry Genomix form SHE Biobank, a Population Health Initiative for Research and Education

With a focus on ethnic minorities, the SHE Biobank provides an infrastructure for boosting research and education and improves response to pandemics.

April 23, 2020, Massachusetts and San Francisco - Science Health Education (SHE) Center at Dana-Farber Cancer Institute, and Silverberry Genomix, a leading company in digital health based in San Francisco, announced the launch of the SHE Biobank initiative. The SHE Center’s goal is to bring best practices, better health outcomes, and increased stability to developing countries including the Middle East and North America (MENA), a region urgently in need of all three. Navid Madani, Ph.D., the director of the SHE Center and a senior scientist at Dana-Farber Cancer Institute has led educational workshops and training programs in the region which reinforced the understanding of the current lack of health data infrastructure and solidified the need for such platforms in the region.

“The SHE Biobank is a large, long-term study that will investigate the impact of genetic predisposition and environmental exposure to the development of the disease,” said Madani. “Biobanking is crucial to this research and helps researchers, healthcare providers and governments to health policies and assign resources properly. “In recent years, due to advancements in healthcare technologies, data availability, and decreasing DNA sequencing costs, various biobanks have been created around the world.  However, the majority of such projects have been launched in developed countries, contributing to an increasing gap between developed and developing countries. This initiative aims to decrease that gap,” she said.

The SHE Biobank is unique in the educational support it offers researchers to conduct studies and the infrastructure it provides so the data can be put into action for the public good.  It also helps increase the readiness of the healthcare community to prevent or combat future disease outbreaks.

“The recent COVID-19 pandemic has shown the importance of the availability of digital health platforms to provide access to data and enable research and collaboration at scale for large size of population,” said Shayan Mashatian, Founder of Silverberry Genomix. “By making the Silverberry platform available to this critical endeavor, we are facilitating a rapid launch of the project, connecting the researchers, healthcare institutions, and other interested parties so more people can take advantage of scientific advancement, preventing disease or empower emerging field of precision medicine.”

Researchers, universities, government agencies, companies, and foundations as well as individual participants, are invited to participate in the initiative.

For more information about the initiative visit or contact

About SHE Center at Dana-Farber Institute, Harvard Medical School

Science Health Education Center (SHE) is a collaborative hub that promotes the Middle East and North Africa (MENA) region relevant research and capacity building through international training and scientific investigation, creating synergies between the MENA healthcare professionals and the Dana-Farber and Harvard communities. For more information visit

About Silverberry Genomix

Silverberry Genomix is a leading digital health platform that utilizes AI and machine learning to provide personalized assessments and recommendations to optimize health and wellness plans. By offering a DNA Testing Kit, anyone can take the test and receive a personalized assessment as well as a wide range of recommendations. Those with an existing DNA file may upload their file and get access to Comprehensive DNA Health Reports. For more information visit

Media Contacts

For all inquiries, call 617-632-4090 and ask to speak to a member of the media team. Please direct emails to

Posted in News.